I am immensely pleased to see that a woman I love and deeply respect is championing the cause of the fight against breast cancer, a topic that is close to my heart, even though fortunately mine was benign. Thank you to Helena, Javi, and everyone who will participate in highlighting this event ❤️ (translated)
I remind you of these solidarity events on two delicate topics such as breast cancer prevention and blood and bone marrow donation. Those who can go should support, and please, these events are not for seeking photos and attention from guys; don’t ruin something so important. 🙏🏼 (translated)
Elena Pero, a historical tennis commentator and authoritative voice in Italian sports journalism, has died at the age of 60 due to cancer, after experiencing symptoms of discomfort and a persistent cold even during the warm days at Wimbledon. (translated)
Screening for lung tumors using low-dose computed tomography in at-risk populations can reduce mortality and improve survival, according to a study by the International Agency for Research on Cancer. (translated)
The Komen Italy campaign, in collaboration with the Ministry of Culture and Health, offers free visits for over 6,000 women and promotes breast cancer prevention, highlighting that 40% of cases could be avoided through healthy lifestyles. (translated)
A team of researchers from the Wake Forest University School of Medicine has identified the SIRPα protein as responsible for the spread of breast cancer tumor cells to the brain, making them more aggressive and weakening the brain's immune defenses. (translated)
These tests could change the paradigm of oncology: we will move from treating symptomatic or visible tumors to eradicating a few cells intercepted in the bloodstream. Less toxicity from treatments and radically higher chances of healing. (translated)
Imagine being able to detect a tumor before a visible mass appears or the first symptoms arise. It's not science fiction, but the promise of liquid biopsies and the sequencing of circulating tumor DNA (ctDNA). Let's clarify with a thread. (translated)
Domenico Traversa, husband of the late Paola Marella, makes an appeal for urgent and free access to the drug daraxonrasib, which is expensive and currently awaiting approval in Europe, so that cost is not a barrier for patients suffering from pancreatic cancer. (translated)
A new blood test, called PANXEON, is capable of identifying cancer cells of pancreatic tumors in the early stages, increasing the chances of early diagnosis and effective treatment. (translated)
Aveva tre anni e una malattia che aveva già resistito quasi a tutto. L’epatoblastoma, un raro tumore del fegato dell’infanzia, era tornato dopo tre cicli di chemioterapia, l’asportazione del tumore primitivo e due interventi sulle metastasi polmonari. Una nuova lesione, vicina al cuore, non era operabile. “Non poteva ricevere altra chemioterapia e non poteva essere operato”, spiega a Salute il professor David Steffin del Centro di terapia genica e cellulare del Texas Children’s Hospital. “Senza l’ingresso nel nostro studio clinico, sarebbe andato verso le cure palliative”. Oggi quel bambino fa una vita del tutto normale e la remissione completa dura da più di un anno. A produrre questo risultato sono state cellule immunitarie del bambino trasformate in laboratorio per riconoscere e distruggere le cellule tumorali e reinfuse nel piccolo paziente. La vicenda riguarda per ora un singolo paziente, all’interno di uno studio clinico di fase 1, eppure ha attirato molta attenzione perché tocca uno dei grandi limiti di questo tipo avanzato di immunoterapia, noto come CAR-T: la difficoltà a funzionare nei tumori solidi. L’intervista di Giuliano Aluffi su Repubblica Salute #rep #epatoblastoma #immunoterapia #salute
The news of a complete remission of metastatic liver cancer following an experimental therapy is circulating. In a child. Published in a prestigious journal. We will need to understand if the response will be lasting, but it is obviously great news. Not if, but when. (translated)
An innovative treatment that uses low-intensity pulsed electromagnetic fields has shown promising results in reprogramming immune system cells to attack tumor cells in breast cancer, but clinical studies are needed to verify its effectiveness in humans. (translated)
The article highlights the importance of genetics in the identification and prevention of familial and hereditary cancer, noting that between 5% and 10% of tumors have a hereditary component, which allows for the implementation of early detection measures and personalized treatments. (translated)
Emma Bonino died today in Rome after fighting against a pulmonary microcytoma, a rare aggressive form of lung cancer primarily associated with tobacco smoking. (translated)
Emma Bonino, former president of +Europa and historic leader of the Radical Party, has died at the age of 78 after announcing in 2015, through a phone call to Radio Radicale, that she had lung cancer in her left lung and had started chemotherapy treatment, declaring in 2023 that she was cured. (translated)
One of the most promising innovations are the T-Cell Engagers, antibodies that can bring immune system cells close to tumor cells, almost acting as a bridge between the two and facilitating the elimination of the tumor by the immune system. (translated)
Minithread on small cell lung cancer. It is an aggressive form of cancer and accounts for 15% of lung tumors. Almost always associated with smoking, it is also known for its rapid spread. Often, we see metastases already at diagnosis. (translated)
The genetic analysis of nearly a thousand prostate tumors reveals combinations of DNA alterations that affect 85% of cases and allows for patient stratification to define more suitable therapies. (translated)
A new injectable hydrogel, developed by Spanish researchers, allows for localized and sustained administration of chemotherapy in solid tumors, demonstrating antitumor activity in preclinical models of ovarian cancer and glioblastoma. (translated)
